FibroGen, Inc (FGEN) Covered Calls
FibroGen Inc is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
There are no covered calls available for FibroGen, Inc.
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
FibroGen, Inc. operates as a research-based biopharmaceutical company that engages in the discovery, development and commercialization of therapeutics to treat unmet medical needs. It focuses on its experience in fibrosis and hypoxia-induced factor biology to generate multiple programs targeting various therapeutic areas. The company product candidate are roxadustat, or FG-4592, is an oral small molecule inhibitor of HIF prolyl hydroxylases, or HIF-PHs, in Phase 3 clinical development for the treatment of anemia in chronic kidney disease, or CKD. FibroGen was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
| Top 10 Open Interest For Nov 21 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | IBIT covered calls | 6. | TLT covered calls | 1. | INBX covered calls | |
| 2. | KVUE covered calls | 7. | HYG covered calls | 2. | UUUU covered calls | |
| 3. | NVDA covered calls | 8. | EEM covered calls | 3. | DNUT covered calls | |
| 4. | SLV covered calls | 9. | QQQ covered calls | 4. | BITF covered calls | |
| 5. | GLD covered calls | 10. | INTC covered calls | 5. | CIFR covered calls | |
Want more examples? FGD Covered Calls | FGM Covered Calls
